Document Detail

Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
MedLine Citation:
PMID:  3099236     Owner:  NLM     Status:  MEDLINE    
In prolactinoma patients, the unresponsiveness of prolactin (PRL) to dynamic tests with thyrotropin-releasing hormone (TRH) or dopamine agonist or antagonist drugs suggests that the disease is caused by the failure of central dopaminergic inhibition. The absence of PRL secretory response to dopamine or TRH in prolactinoma patients also may be an effect of the disease. Twenty-six women diagnosed by dynamic tests and radiologic examination as having PRL-secreting adenoma were treated surgically (15) or with bromocriptine (11) and their condition was evaluated one to three years later by TRH, nomifensine, and domperidone tests. Basal PRL levels decreased after surgery and bromocriptine treatment. At the time of the follow-up study, PRL levels were elevated in six of the 15 surgically treated patients and in six of the 11 treated with bromocriptine. Thyrotropin-releasing hormone, nomifensine, and domperidone produced standard PRL responses in normoprolactinemic patients but not in hyperprolactinemic patients. These results indicate that the alteration of TRH or dopaminergic receptors in the regulation of PRL secretion in prolactinoma is related to the disease and disappears when the tumor is removed or treated successfully with bromocriptine.
V De Leo; F Petraglia; S Sardelli; S Danero; A R Genazzani; N D'Antona
Related Documents :
3262286 - Arterial embolization of adrenal tumors: results in nine cases.
11012566 - Tall stature in familial glucocorticoid deficiency.
12784096 - Manifestation of thyrotoxic periodic paralysis in two patients with adrenal adenomas an...
11193716 - Growth factors in clinical practice.
7840356 - Postictal and chronic psychoses in patients with temporal lobe epilepsy.
1587406 - Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  69     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  1987 Jan 
Date Detail:
Created Date:  1987-01-29     Completed Date:  1987-01-29     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  99-103     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenoma / drug therapy,  secretion*,  surgery
Bromocriptine / therapeutic use*
Domperidone / diagnostic use
Nomifensine / diagnostic use
Pituitary Neoplasms / drug therapy,  secretion*,  surgery
Prolactin / secretion*
Thyrotropin-Releasing Hormone / diagnostic use
Reg. No./Substance:
24305-27-9/Thyrotropin-Releasing Hormone; 24526-64-5/Nomifensine; 25614-03-3/Bromocriptine; 57808-66-9/Domperidone; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prognostic factors: cisplatin regimens for patients with ovarian cancer after failure of chemotherap...
Next Document:  Eagle's syndrome: a comparison of intraoral versus extraoral surgical approaches.